Triathlon PSR Outcomes Study
- Conditions
- KneeArthroplasty
- Interventions
- Device: Triathlon PSR Tibial Insert
- Registration Number
- NCT04618770
- Lead Sponsor
- Stryker Orthopaedics
- Brief Summary
This study is a prospective, open-label, post-market, non-randomized, multi-center clinical evaluation of the Triathlon Total Knee System using the Triathlon PSR Tibial Insert for primary total knee arthroplasty (TKA) in a consecutive series of patients who meet the eligibility criteria. The SF-36 score of subjects receiving the Triathlon Total Knee with the Triathlon PSR insert is expected to be comparable with that of subjects receiving historical Triathlon PS cemented constructs.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 37
- Patient has signed an IRB/EC approved; study specific Informed Patient Consent Form.
- Patient is a male or non-pregnant female, skeletally mature, age 18-75 years at time of study device implantation.
- Patient has a diagnosis of Non-Inflammatory Degenerative Joint Disease (NIDJD).
- Patient is a candidate for primary cemented total knee replacement.
- Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.
- Patient has a Body Mass Index (BMI) > 45.
- Patient is already participating in the study for a contralateral total knee replacement.
- Patient has a diagnosis of avascular necrosis or inflammatory arthritis.
- Patient has an active or suspected latent infection in or about the affected knee joint at time of study device implantation.
- Patient has any mental or neuromuscular disorder which would create an unacceptable risk of prosthesis instability, prosthesis fixation failure, or complications in postoperative care.
- Patient has a compromised bone stock which cannot provide adequate support to the prosthesis.
- Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. > 30 days).
- Patient is diagnosed with lumbar radicular pain.
- Patient has severe instability of the knee joint secondary to the absence of collateral ligament integrity and function.
- Patient has a known sensitivity to device materials.
- Patient is a prisoner.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Triathlon PSR Tibial Insert Triathlon PSR Tibial Insert Cases receiving a Triathlon Total Knee with the Triathlon PSR Tibial Insert
- Primary Outcome Measures
Name Time Method Mean SF-36 Physical Component Score pre-operative, 6 weeks, 1 year The SF-36 is a 36-item patient completed questionnaire to measure general health and well-being. It includes physical and mental status component sub scores; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.
- Secondary Outcome Measures
Name Time Method Survivorship of Triathlon PSR Insert 1 Year All-cause survivorship of the Triathlon PSR Tibial Insert will be evaluated through 10 year.
Range of Motion PreOp, 6 weeks, 1 year Range of Motion evaluates how much the knee can be bent and straightened. The normal range of motion is typically 0 to 135 degrees.
EuroQol-5 Dimension (EQ-5D) PreOp, 6 week, 1 year The EuroQol-5 Dimension (EQ-5D) is a subject-completed questionnaire designed to assess subject health state values. The EQ-5D consists of 2 areas; EQ-5D descriptive system and the visual analogue scale (VAS). The EQ-5D descriptive system comprises the following five dimensions: mobility self care, usual activities, pain/comfort and anxiety/depression. Each dimension has 3 levels indicating no problems, some problems or extreme problems. The index values on a scale between -1 (low) and 1 (high) are showing the average health status according to the 5 dimensions: A low score shows worse health and a high score shows better health.
With the EQ VAS the respondents can report their perceived health status with a grade ranging from 0 (the worst possible health status) to 100 (the best possible health status).
Trial Locations
- Locations (1)
OrthoCarolina
🇺🇸Charlotte, North Carolina, United States